Inicio › Cáncer de pulmón de células no pequeñas › Kansas › Overland Park
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Overland Park, KS
16 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Overland Park y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
ReclutandoFase 1/2
- Kansas City Cancer Center /ID# 273679, Overland Park
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
ReclutandoFase 3
- Research Site, Leawood · A 3 mi de distancia
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ReclutandoFase 2
- University of Kansas Cancer Center, Fairway · A 3 mi de distancia
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Saint Luke's South Hospital, Overland Park
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- MidAmerica Cancer Care - Research, Merriam · A 3 mi de distancia
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ReclutandoFase 3
- University of Kansas Cancer Center-Overland Park, Overland Park
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
- The University of Kansas Cancer Center, Investigational Drug Services, Fairway · A 3 mi de distancia
- The University of Kansas Clinical Research Center, Fairway · A 3 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · A 3 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · A 3 mi de distancia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · A 3 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · A 3 mi de distancia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
ReclutandoFase 1/2
- The University of Kansas Cancer Center, Fairway · A 3 mi de distancia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
ReclutandoFase 1/2
- The University of Kansas Cancer Center (KUCC), Fairway · A 3 mi de distancia
A Study of IBI363 in Subjects with Advanced Solid Malignancies
ReclutandoFase 2
- University of Kansas Medical Center (KUMC), Fairway · A 3 mi de distancia
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
ReclutandoEstudio observacional
- The University of Kansas Cancer Center (KUCC), Fairway · A 3 mi de distancia
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Overland Park
- Leucemia mielógena aguda11 estudios
- Cáncer de pulmón11 estudios
- Cáncer de seno10 estudios
- Fibrilación auricular8 estudios
- Cáncer del colon y del recto8 estudios
- Obesidad7 estudios
- Cáncer de páncreas7 estudios
- Cáncer de próstata7 estudios
- Melanoma6 estudios
- Sobrepeso6 estudios
- Cáncer de ovario6 estudios
- Cáncer (todos los tipos)5 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.